文献速递乳房整形与再造创面修复

Goldilocks乳房切除术中影响组织扩张器使用与乳头乳晕保留的风险因素

Risk factors affecting tissue expander use and nipple areolar complex sparing in Goldilocks mastectomy.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-03-10

单机构回顾性队列研究纳入26例(41侧乳房)Goldilocks乳房切除术患者,评估乳头乳晕保留与即刻组织扩张器重建的风险因素。总体主要并发症发生率为19.5%,糖尿病与皮瓣坏死显著相关(p=0.0092)。

要点

  • 糖尿病显著增加Goldilocks重建术后皮瓣坏死风险(p=0.0092)。
  • 组织扩张器丢失中80%由感染或坏死导致。
  • 高龄、高血压和高BMI呈并发症升高趋势但未达统计学显著。

核心结论

  • 糖尿病显著增加Goldilocks重建中皮瓣坏死风险,应在选择乳头乳晕保留或即刻组织扩张器置入时重点考虑。

研究设计与样本

  • 单机构回顾性队列研究,纳入2021年8月至2024年6月由单一术者完成的26例患者(41侧乳房)Goldilocks乳房切除术。

主要发现

  • 总体主要并发症发生率为19.5%(乳房),次要并发症为9.8%。
  • 无血肿或组织扩张器外露病例。
  • 组织扩张器丢失的80%由感染或坏死导致。
  • 糖尿病与乳房切除皮瓣坏死显著相关(p=0.0092)。
  • 其他合并症或乳房测量指标与感染、坏死、再入院、再手术或组织扩张器丢失无显著关联。

关键数值与推荐

  • 手术构成:单纯Goldilocks占29.3%,乳头乳晕保留Goldilocks占26.8%,Goldilocks联合即刻组织扩张器占21.9%,乳头乳晕保留Goldilocks联合即刻组织扩张器占21.9%。
  • 患者平均年龄55.6岁,平均体重指数35.8 kg/m2。

临床怎么用

  • 合并糖尿病的患者行Goldilocks重建时,应警惕皮瓣坏死风险,尤其在规划乳头乳晕保留或即刻组织扩张器置入时需谨慎选择。

局限性

  • 单机构、单术者、回顾性设计,样本量较小(26例患者、41侧乳房)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Goldilocks mastectomy offers breast mound reconstruction using residual mastectomy skin flaps and has become a valuable option for patients with macromastia or elevated surgical risk. Increasingly, the technique is being combined with nipple-areolar complex preservation and immediate implant-based reconstruction; however, the risk factors that influence nipple viability and tissue expander success remain poorly defined. This single-institution retrospective cohort study evaluated 26 patients (41 breasts) who underwent Goldilocks mastectomy performed by a single surgeon between August 2021 and June 2024. Procedures included Goldilocks alone (29.3%), nipple-areolar complex-sparing Goldilocks (26.8%), Goldilocks with immediate tissue expander placement (21.9%), and nipple-areolar complex-sparing Goldilocks with immediate tissue expander placement (21.9%). The mean patient age was 55.6 years and mean body mass index was 35.8 kg/m2. Overall complication rates included major events in 19.5% of the breasts and minor events in 9.8%. There were no cases of hematoma or tissue expander exposure. Most tissue expander losses (80%) were from infection or necrosis. Diabetes was significantly associated with mastectomy skin flap necrosis (p = 0.0092), whereas no other comorbidities or breast measurements were significantly associated with infection, necrosis, readmission, reoperation, or tissue expander loss. Trends toward higher complications were observed in patients with advanced age, hypertension, and elevated body mass index, though these did not reach statistical significance. These findings indicate that diabetes meaningfully increases necrosis risk in Goldilocks reconstruction and should strongly influence patient selection when planning nipple-areolar complex-sparing procedures or immediate tissue expander placement.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Kreul T, Anderson C, Thomas J, et al. Risk factors affecting tissue expander use and nipple areolar complex sparing in Goldilocks mastectomy. J Plast Reconstr Aesthet Surg. 2026. PMID: 41886867. doi:10.1016/j.bjps.2026.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。